1-6 of 6
Jillian Lykon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Toxicity and Outcomes in Octo- and Nonagenarians with AML Treated with Venetoclax and Hypomethylating Agent Therapy

Ellen Madarang, Jillian Lykon, Wei Zhao, Mikkael A. Sekeres, Terrence Bradley, Namrata Sonia Chandhok, Justin Taylor, Tulay Koru-Sengul, Sunil G. Iyer, Jacopo Nanni, Cristina Papayannidis, Ryan M Miller, Ashwin Kishtagari, Michael R. Savona, Jason Gilbert, Daniel A. Pollyea, David A. Sallman, Najla Al Ali, Rami S. Komrokji, Justin Watts
Journal: Blood
Blood (2022) 140 (Supplement 1): 3306–3308.
https://doi.org/10.1182/blood-2022-170771
Published: 2022
Journal Articles

Outcome with Intensive Chemotherapy Compared to Hypomethylating Agent- Based Induction in Patients Aged 70 Years or Older with Newly Diagnosed Favorable Risk Acute Myeloid Leukemia

Somedeb Ball, Akriti G Jain, Luis E. E. Aguirre, Najla Al Ali, Jan Philipp Bewersdorf, Alexander Hayden, Alexa J. Siddon, Jillian Lykon, Ellen Madarang, David A. Sallman, Eric Padron, Kendra Sweet, Jeffrey E. Lancet, Justin M Watts, David M Swoboda, Daniel A. Pollyea, Amer M. Zeidan, Rami S. Komrokji
Journal: Blood
Blood (2021) 138 (Supplement 1): 2331.
https://doi.org/10.1182/blood-2021-151988
Published: 2021
Journal Articles

Octogenarians with AML Can Have Durable Remissions with Venetoclax and Hypomethylating Agent Therapy Despite Significant Dose Reductions

Ellen Madarang, Jillian Lykon, Wenhui Li, Sunil Iyer, Michele Stanchina, Nina Nguyen, Terrence Bradley, Mikkael A. Sekeres, Justin Taylor, Namrata Sonia Chandhok, Justin Watts
Journal: Blood
Blood (2021) 138 (Supplement 1): 1259.
https://doi.org/10.1182/blood-2021-151738
Published: 2021
Journal Articles

Use of High Dose Cytarabine (HiDAC) for Post-Remission or Re-Induction Therapy Is Safe and Effective in Select Older AML Patients

Jillian Lykon, Ellen Madarang, Nina Nguyen, Wenhui Li, Sunil G. Iyer, Michele Stanchina, Terrence Bradley, Justin Taylor, Namrata Sonia Chandhok, Mikkael A. Sekeres, Justin Watts
Journal: Blood
Blood (2021) 138 (Supplement 1): 4422.
https://doi.org/10.1182/blood-2021-153143
Published: 2021
Journal Articles

Real World Outcomes of Liposomal Daunorubicin and Cytarabine Versus 7+3 in Patients with Secondary Acute Myeloid Leukemia

Ellen Madarang, PharmD, Jillian Lykon, PharmD, Nina Nguyen, MD, Justin M. Watts, MD, Terrence J Bradley, MD, Namrata S Chandhok, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-142595
Published: 2020
Journal Articles

Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation

Yehuda E. Deutsch, MD, Robert Wilkinson, PharmD, Amanda Brahim, PharmD, Stephanie Boisclair, MD, Jose Sandoval-Sus, MD, Annie Kuehnel, APRN, Terrence J Bradley, MD, Chetasi Talati, MD, Ellen Madarang, PharmD, Jillian Lykon, PharmD, Justin M. Watts, MD, David A Sallman, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD, Hugo F. Fernandez, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3896.
https://doi.org/10.1182/blood-2019-129331
Published: 2019